Literature DB >> 21248250

Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.

Magdalena Paolino1, Christine B F Thien, Thomas Gruber, Reinhard Hinterleitner, Gottfried Baier, Wallace Y Langdon, Josef M Penninger.   

Abstract

E3 ubiquitin ligases have been placed among the essential molecules involved in the regulation of T cell functions and T cell tolerance. However, it has never been experimentally proven in vivo whether these functions indeed depend on the catalytic E3 ligase activity. The Casitas B-cell lymphoma (Cbl) family protein Cbl-b was the first E3 ubiquitin ligase directly implicated in the activation and tolerance of the peripheral T cell. In this study, we report that selective genetic inactivation of Cbl-b E3 ligase activity phenocopies the T cell responses observed when total Cbl-b is ablated, resulting in T cell hyperactivation, spontaneous autoimmunity, and impaired induction of T cell anergy in vivo. Moreover, mice carrying a Cbl-b E3 ligase-defective mutation spontaneously reject tumor cells that express human papilloma virus Ags. These data demonstrate for the first time, to our knowledge, that the catalytic function of an E3 ligase, Cbl-b, is essential for negative regulation of T cells in vivo. Thus, modulation of the E3 ligase activity of Cbl-b might be a novel modality to control T cell immunity in vaccination, cancer biology, or autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248250     DOI: 10.4049/jimmunol.1003390

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.

Authors:  Hui Guo; Guilin Qiao; Haiyan Ying; Zhenping Li; Yixia Zhao; Yanran Liang; Lifen Yang; Stanley Lipkowitz; Josef M Penninger; Wallace Y Langdon; Jian Zhang
Journal:  Cell Rep       Date:  2012-05-31       Impact factor: 9.423

2.  On the Mechanism of T cell receptor down-modulation and its physiological significance.

Authors:  David Escors; Christopher Bricogne; Frederick Arce; Grazyna Kochan; Katarzyna Karwacz
Journal:  J Biosci Med       Date:  2011-01

Review 3.  Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

Authors:  Yu Fujita; Roberto Tinoco; Yan Li; Daniela Senft; Ze'ev A Ronai
Journal:  Trends Mol Med       Date:  2019-03-18       Impact factor: 11.951

4.  Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation.

Authors:  D Saadoun; B Terrier; J Bannock; T Vazquez; C Massad; I Kang; F Joly; M Rosenzwajg; D Sene; P Benech; L Musset; D Klatzmann; E Meffre; P Cacoub
Journal:  Arthritis Rheum       Date:  2013-04

5.  Impairment of non-muscle myosin IIA in human CD4+ T cells contributes to functional deficits in the elderly.

Authors:  Stefania Cane; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Cell Mol Immunol       Date:  2011-10-10       Impact factor: 11.530

6.  Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.

Authors:  Mai Fujiwara; Emily J Anstadt; Kamal M Khanna; Robert B Clark
Journal:  Clin Immunol       Date:  2015-03-28       Impact factor: 3.969

Review 7.  RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis.

Authors:  Stanley Lipkowitz; Allan M Weissman
Journal:  Nat Rev Cancer       Date:  2011-08-24       Impact factor: 60.716

Review 8.  Aplastic anemia is related to alterations in T cell receptor signaling.

Authors:  Yankai Xiao; Suwen Zhao; Bo Li
Journal:  Stem Cell Investig       Date:  2017-10-24

9.  Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes.

Authors:  Daniel Abate-Daga; Ken-ichi Hanada; Jeremy L Davis; James C Yang; Steven A Rosenberg; Richard A Morgan
Journal:  Blood       Date:  2013-07-16       Impact factor: 22.113

Review 10.  Regulation of immune responses by E3 ubiquitin ligase Cbl-b.

Authors:  Rong Tang; Wallace Y Langdon; Jian Zhang
Journal:  Cell Immunol       Date:  2018-11-07       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.